Six countries (Belgium, The Netherlands, Switzerland, Finland, Spain and Germany) sampled a variable number of nursing units based on hospital size (e.g. Belgium: 4 nursing units in hospitals with <500 beds; 6 nursing units in hospitals with 500 beds or more).
In order to conveniently adjust the output power of the UWB sample device, a variable attenuator is employed.
The findings from the present pilot study are limited by the small, clinically heterogeneous patient sample with a variable time interval after surgery.
Each voice can play its sample at a variable rate, with Gaussian interpolation, stereo panning, and ADSR, linear, non-linear, or direct volume envelope adjustment.
Inclusion of time since blood sample as a variable showed that it was not an important risk factor for failure (t=−1.454, p=0.1459).
To detect differences in the cDNA expression level for each sample set, a variable number of amplification cycles, between 20 and 24 depending on gene templates, were tested.
The method is based on the observation that to sample a random variable one can sample uniformly from the region under the graph of its density function.
Temperature-dependent magnetization was conducted on three selected samples with a variable field transition balance (VFTB) under a background magnetic field of about 100 mT.
Among them, 94 samples resulted a variable count of WSSV load ranging from 2.1 × 108 to 2.64 × 1014 copies/g of shrimp tissue.
The collected samples at a variable interval of time were filtered using filter papers of 0.45 µM size (Make: Millipore) to remove the traces of solid particles.
Fig. 3 PEDOT PSS sheet resistance on drop cast NFC-G samples with a variable NFC concentration at a constant glycerol concentration of 5.0 wt% and b constant NFC concentration of 0.1 wt% with variable glycerol concentration.
